The Business Roundtable, led by Jamie Dimon, gives a new definition of the "purpose of a corporation."Marketsread more
Stocks rose sharply on Monday as Treasury yields rebounded, quelling fears of a possible recessionUS Marketsread more
Powell will have the opportunity if not to walk back the "midcycle" assessment then to at least provide some further explanation about what it means.Economyread more
Twitter and Facebook have suspended numerous accounts that are believed to be tied to a state-backed information campaign originating from inside China.Technologyread more
Leaked documents from Google give fresh ammo to conservative lawmakers who have already accused Google and other tech companies of political bias.Technologyread more
J.P. Morgan estimates the average annual tariff cost per household will be $1,000 with the new round of Trump's tariffs.Marketsread more
Stasior left Apple earlier this year. Prior to his time in charge of Siri, he was a top executive at Amazon.Technologyread more
Sequoia's Michael Moritz says that direct listings worked for Spotify and Slack and will become more common for companies with "courage and intelligence."Technologyread more
Shares of embattled utility PG&E plummeted after a judge ruled that a jury can decided whether it should pay up to $18 billion in damages.Marketsread more
The attacks come after state and local ransomware attacks in New York, Louisiana, Maryland and Florida resulted in the loss of significant sums.Technologyread more
Since its IPO 15 years ago, Google has become more and more powerful. Today, that power is being highly scrutinized.Technologyread more
* Bayer fetches 1.17 bln eur in equity value for 60% stake
* Bayer also sells real estate worth 180 mln eur
* Lanxess' 40% stake worth 780 mln eur plus profit contribution
* Bayer reduces debt after $63 bln Monsanto takeover (Adds background Bayer's plans, Lanxess)
FRANKFURT, Aug 6 (Reuters) - German chemical groups Bayer and Lanxess have agreed to sell chemical park operator Currenta to Macquarie Infrastructure and Real Assets (MIRA) for an enterprise value of 3.5 billion euros ($3.9 billion).
That includes net debt and pension obligations and a related real estate portfolio that Bayer will transfer to Macquarie, the sellers said on Tuesday.
Reuters reported last September initial plans by Bayer to divest its 60% stake in the chemical park operator, part of a string of assets it has put on the block to slash its debt since its $63 billion takeover of Monsanto last year.
It has recently sold consumer health brands Dr. Scholl's and Coppertone and is looking for a new owner for its animal health business.
Bayer's stake in Currenta fetched an equity value of about 1.17 billion euros after deducting net debt and pension obligations. In addition, Bayer agreed to sell real estate on which Currenta operates for 180 million euros.
Lanxess, which had initially intended to hold on to its stake, realised an equity value of about 780 million euros for its 40%, in addition to an unspecified participation in profits until the transaction is completed.
Bayer had initially planned to sell the Currenta stake - a legacy asset with little benefit for its core drugs and agriculture businesses - to its former industrial chemicals subsidiary Covestro, but could not agree on a valuation.
Covestro and Lanxess, both former Bayer businesses, are Currenta's main customers.
Reuters reported in March that Macquarie had emerged as the leading bidder for Bayer's stake, beating out rival suitors DWS and KKR.
($1 = 0.8929 euros) (Reporting by Ludwig Burger; Editing by Jan Harvey)